BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 26764241)

  • 1. Genetic dysfunction of serotonin 2A receptor hampers response to antidepressant drugs: A translational approach.
    Qesseveur G; Petit AC; Nguyen HT; Dahan L; Colle R; Rotenberg S; Seif I; Robert P; David D; Guilloux JP; Gardier AM; Verstuyft C; Becquemont L; Corruble E; Guiard BP
    Neuropharmacology; 2016 Jun; 105():142-153. PubMed ID: 26764241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-HT₂A receptor inactivation potentiates the acute antidepressant-like activity of escitalopram: involvement of the noradrenergic system.
    Quesseveur G; Repérant C; David DJ; Gardier AM; Sanchez C; Guiard BP
    Exp Brain Res; 2013 Apr; 226(2):285-95. PubMed ID: 23411676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Converging translational evidence for the involvement of the serotonin 2A receptor gene in major depressive disorder.
    Petit AC; Quesseveur G; Gressier F; Colle R; David DJ; Gardier AM; Ferreri F; Lépine JP; Falissard B; Verstuyft C; Guiard BP; Corruble E
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Oct; 54():76-82. PubMed ID: 24801750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered response to the selective serotonin reuptake inhibitor escitalopram in mice heterozygous for the serotonin transporter: an electrophysiological and neurochemical study.
    Guiard BP; Mansari ME; Murphy DL; Blier P
    Int J Neuropsychopharmacol; 2012 Apr; 15(3):349-61. PubMed ID: 21439106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between serotonin 2A receptor (HTR2A), serotonin transporter (SLC6A4) and brain-derived neurotrophic factor (BDNF) gene polymorphisms and citalopram/sertraline induced sexual dysfunction in MDD patients.
    Oz MD; Baskak B; Uckun Z; Artun NY; Ozdemir H; Ozel TK; Ozguven HD; Suzen HS
    Pharmacogenomics J; 2020 Jun; 20(3):443-450. PubMed ID: 31792367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olanzapine augments the effect of selective serotonin reuptake inhibitors by suppressing GABAergic inhibition via antagonism of 5-HT₆ receptors in the dorsal raphe nucleus.
    Asaoka N; Nagayasu K; Nishitani N; Yamashiro M; Shirakawa H; Nakagawa T; Kaneko S
    Neuropharmacology; 2015 Aug; 95():261-8. PubMed ID: 25863120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin receptor 2A gene polymorphism (-1438A/G) and short-term treatment response to citalopram.
    Choi MJ; Kang RH; Ham BJ; Jeong HY; Lee MS
    Neuropsychobiology; 2005; 52(3):155-62. PubMed ID: 16127283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-HT2A receptor -1438 G/A polymorphism and serotonergic antidepressant-induced sexual dysfunction in male patients with major depressive disorder: a prospective exploratory study.
    Liang CS; Ho PS; Chiang KT; Su HC
    J Sex Med; 2012 Aug; 9(8):2009-16. PubMed ID: 22612784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between single nucleotide polymorphisms in 5-HT2A signal transduction-related genes and the response efficacy to selective serotonin reuptake inhibitor treatments in Chinese patients with major depressive disorder.
    Li HF; Yu X; Yang K; He CY; Kou SJ; Cao SX; Xie GR
    Genet Test Mol Biomarkers; 2012 Jul; 16(7):667-71. PubMed ID: 22480177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HTR2A is associated with SSRI response in major depressive disorder in a Japanese cohort.
    Kishi T; Yoshimura R; Kitajima T; Okochi T; Okumura T; Tsunoka T; Yamanouchi Y; Kinoshita Y; Kawashima K; Naitoh H; Nakamura J; Ozaki N; Iwata N
    Neuromolecular Med; 2010 Sep; 12(3):237-42. PubMed ID: 19937159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Female sexual dysfunction in patients with major depressive disorder (MDD) treated with selective serotonin reuptake inhibitor (SSRI) and its association with serotonin 2A-1438 G/A single nucleotide polymorphisms.
    Masiran R; Sidi H; Mohamed Z; Mohd Nazree NE; Nik Jaafar NR; Midin M; Das S; Mohamed Saini S
    J Sex Med; 2014 Apr; 11(4):1047-1055. PubMed ID: 24533444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variation in the tryptophan hydroxylase 2 gene moderates depressive symptom trajectories and remission over 8 weeks of escitalopram treatment.
    Su YA; Li JT; Dai WJ; Liao XM; Dong LC; Lu TL; Bousman C; Si TM
    Int Clin Psychopharmacol; 2016 May; 31(3):127-33. PubMed ID: 26745768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of serotonin transporter (SLC6A4) and receptor (5HTR1A, 5HTR2A) polymorphisms with response to treatment with escitalopram in patients with major depressive disorder: A preliminary study.
    Basu A; Chadda RK; Sood M; Kaur H; Kukreti R
    Indian J Med Res; 2015 Jul; 142(1):40-5. PubMed ID: 26261165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin 2A receptor polymorphism rs3803189 mediated by dynamics of default mode network: a potential biomarker for antidepressant early response.
    Sun Y; Tao S; Tian S; Shao J; Mo Z; Wang X; Wang H; Zhao P; Chen Z; Yao Z; Lu Q
    J Affect Disord; 2021 Mar; 283():130-138. PubMed ID: 33548906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment.
    McMahon FJ; Buervenich S; Charney D; Lipsky R; Rush AJ; Wilson AF; Sorant AJM; Papanicolaou GJ; Laje G; Fava M; Trivedi MH; Wisniewski SR; Manji H
    Am J Hum Genet; 2006 May; 78(5):804-814. PubMed ID: 16642436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variation in HTR2A influences serotonin transporter binding potential as measured using PET and [11C]DASB.
    Laje G; Cannon DM; Allen AS; Klaver JM; Peck SA; Liu X; Manji HK; Drevets WC; McMahon FJ
    Int J Neuropsychopharmacol; 2010 Jul; 13(6):715-24. PubMed ID: 20047709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-HT2A gene variants influence specific and different aspects of antidepressant response in Japanese and Italian mood disorder patients.
    Kato M; Zanardi R; Rossini D; De Ronchi D; Okugawa G; Kinoshita T; Colombo C; Serretti A
    Psychiatry Res; 2009 May; 167(1-2):97-105. PubMed ID: 19361869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HTR2A gene variation is involved in antidepressant treatment response.
    Lucae S; Ising M; Horstmann S; Baune BT; Arolt V; Müller-Myhsok B; Holsboer F; Domschke K
    Eur Neuropsychopharmacol; 2010 Jan; 20(1):65-8. PubMed ID: 19758789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of BDNF, HTR2A, TPH1, SLC6A4, and COMT polymorphisms with tDCS and escitalopram efficacy: ancillary analysis of a double-blind, placebo-controlled trial.
    Brunoni AR; Carracedo A; Amigo OM; Pellicer AL; Talib L; Carvalho AF; Lotufo PA; Benseñor IM; Gattaz W; Cappi C
    Braz J Psychiatry; 2020 Apr; 42(2):128-135. PubMed ID: 31721892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of monoamine oxidase A and serotonin receptor 2A polymorphisms in SSRI antidepressant activity.
    Cusin C; Serretti A; Zanardi R; Lattuada E; Rossini D; Lilli R; Lorenzi C; Smeraldi E
    Int J Neuropsychopharmacol; 2002 Mar; 5(1):27-35. PubMed ID: 12057029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.